The in vitro antibacterial activity of nine cephalosporins (cephalothin, cephaloridine, cephalexin, cefazolin, cefamandole, cefuroxime, cefatrizine, cefoxitin, and cefazaflur) was determined against 344 strains ofEnterobacteriaceae and 99 nonfermentative gram-negative bacilli. Cefamandole, cefazaflur, and cefuroxime were the most active cephalosporins against the Enterobacteriaceae (with the exception of Serratia marcescens). However, cefoxitin was the only cephalosporin that inhibited all 30 S. marcescens strains in a concentration of 16 ,g/ml and was by far the most active compound against selected cephalothin-resistant strains ofEscherichia coli, Klebsiella, and Proteus mirabilis. Acinetobacter spp. were inhibited best by cefuroxime, but none of the cephalosporins had appreciable activity against the Pseudomonas spp.
Infections with gram-negative bacilli constitute a major problem, especially among hospitalized patients. An increasing number of these organisms are resistant to most of the currently used antibiotics. Newly developed cephalosporins may offer a safe alternative treatment.
A serious drawback to the first clinically available cephalosporins, cephalothin, cephaloridine, cephalexin, and cefazolin, is that they have only slight activity against Enterobacter spp., Providencia spp., and indole-positive Proteus spp., and Serratia marcescens and Pseudomonas aeruginosa are completely resistant to these antibiotics. However, recently a number of new cephalosporins have been synthesized that seem to have a markedly broader spectrum against gram-negative bacilli. Among the most promising are cefamandole (2, 4, 5, 7, 10) , cefuroxime (5, 11, 12) , cefatrizine (6, 7, 13, 15) , cefoxitin (3, 7-9, 11, 14) , and cefazaflur (SKF 59962) (1) .
In this study the antibacterial activities of these newer cephalosporins against clinical isolates of 344 Enterobacteriaceae and 99 nonfermentative gram-negative bacilli were compared with each other and with that of the older cephalosporins.
MATERIALS AND METHODS
Clinical isolates of Enterobacteriaceae and nonfermentative gram-negative bacilli were collected during a 2-month period in St. Raphael, the teaching hospital of the University of Leuven. After identification by standard criteria the following numbers of strains were selected for study: 60 Escherichia coli, 55 Klebsiella pneumoniae, 16 Klebsiella oxytoca, 56 Enterobacter spp., 15 Citrobacter freundii, 10 Citrobacter diversus, 62 Proteus mirabilis, 30 Proteus vulgaris, 14 Proteus morganii, 11 Proteus rettgeri, 15 Providencia spp., 30 S. marcescens, 25 Acinetobacter spp., 67 P. aeruginosa, and 7 Pseudomonas spp. The susceptibility of the strains was determined by an agar dilution technique. Overnight cultures in Trypticase soy broth were diluted in sterile Trypticase soy broth and inoculated with an automatic multipoint inoculator (16) to deliver an inoculum of 104 to 105 colony-forming units.
Serial twofold dilutions of the cephalosporins were prepared in sterile distilled water. After the addition of one part of each dilution to nine parts of melted and cooled Diagnostic Sensitivity Test agar (DST Oxoid), the final concentration in the petri dishes ranged from 128 to 0.25 ug/ml. The plates were used on the day of preparation or within 24 h. Pure drugs were obtained from the manufacturers: cephalothin, cephaloridine, cefazolin, cephalexin, and cefamandole from Eli Lilly & Co.; cefuroxime from Glaxo; cefatrizine from Bristol Laboratories; cefoxitin from Merck, Sharp and Dohme; and cefazaflur (SKF 59962) from RIT (Belgium).
Control drug-free plates were similarly inoculated. For Proteus strains, p-nitrophenyl-38-D-glucoside in a final concentration of 50 ,ug/ml was added to the antibiotic plates and to control plates to avoid swarming. After incubation at 37°C for 18 h, the minimal inhibitory concentration (MIC) was recorded as the lowest concentration of antibiotic that completely inhibited growth; the presence of three or less colonies was disregarded.
Clinical susceptibility to an antibiotic was arbitrarily defined as inhibition of strains at or below half the peak levels of antibiotics achieved after the Cefuroxime was the most active cephalosporin against the Acinetobacter spp., followed by cefoxitin and cefamandole (Table 3) .
Cefoxitin was clearly the most active compound against S. marcescens, and cefamandole was active in part of these strains. However, against the Pseudomonas spp. there was scarcely any activity of the cephalosporins. Table 4 shows the geometric means of the MIC values of the different cephalosporins. The newer cephalosporins had clearly lower mean MICs than did the older ones. Against the species of group 1, the lowest mean MICs were obtained with cefamandole (0.8 ,ug/ml), cefazaflur (0.9 ,ig/ml), and cefuroxime (1.5 jig/ml).
Against the species of group 2, the same cephalosporins had the lowest mean MIC values: cefamandole, 3.1 jig/ml; cefuroxime, 7.8 ,ug/ml; and cefazaflur, 10.1 ,g/ml. Cefoxitin took only the fourth place as a whole (14.1 jig/ml) due to its weaker activity against Enterobacter spp. and C. freundii. However, against the indolepositive Proteus spp. and the Providencia spp., cefoxitin was the second best, with a mean MIC of 3.1 jig/ml, cefamandole being most effective with a mean MIC of 2.3 jig/ml. The activity of cefoxitin against S. marcescens, with a mean MIC of 10.4 ,g/ml, was similar to the activity of this antibiotic against the species of group 2 (namely, 10.1 ,ug/ml). Since the activity of all cephalosporins was tested simultaneously on the same inoculum of each species, a direct comparison between the MICs of each cephalosporin and the MIC of cephalothin as a reference was possible for each isolate. Therefore, the linear regression lines of the log MICs between each cephalosporin and cephalothin were calculated for these species, whereby more than half of the isolates were at least susceptible to 128 ,ug of cephalothin per ml (resistance to 128 ,ug/ml was considered as susceptibility to 256 ,ug/ml for convenience in the calculations). In the other species, with more than half of the strains resistant to 128 ,ug of cephalothin per ml, the lack of an exact end point of inhibition made the calculation of regression lines less valuable. In other words, isolates resistant to cephalothin were as a rule less susceptible or even resistant to these other cephalosporins. In contrast, especially cefoxitin and to a lesser extent cefuroxime had very poor correlation coefficients with cephalothin. Cefamandole took a place in between, and cefazaflur tended rather to a parallel susceptibility with cephalothin. Table 6 shows the geometric mean MICs of the different cephalosporins according to the susceptibility of the isolates to cephalothin at a concentration of 16 ,g/ml. The ratio between the geometric mean MIC of the susceptible isolates and of the cephalothin-resistant isolates reflects the degree of cross-resistance or crosssusceptibility with cephalothin. This ratio was 1:26 for cephalothin in the species ofgroup 1 (E. coli, Klebsiella spp., and P. mirabilis). The ratios for cefazolin, cephaloridine, cefamandole, cefatrizine, and cefazaflur were very similar and varied from 1:15 to 1:28. In the species of group 2 (Enterobacter, C. freundii, indole-positive Proteus, Providencia, and Acinetobacter) the ratio between the geometric mean MIC of susceptible and resistant isolates was 1:15 for cephalothin and between 1:8 and 1:19 for cephalexin, cefazaflur, cephaloridine, cefatrizine, and cefazolin. The susceptibility to cefoxitin VOL. 10, 1976 on October 23, 2017 by guest http://aac.asm.org/ was by far the most independent from resistance to cephalothin and was of an equal degree in the species of group 1 (ratio of 1:3) and those of group 2 (ratio of 1:2). Cefamandole showed a definite lowered activity against cephalothinresistant isolates ofthe group 1 species (ratio of 1:25), but much less against those of group 2 (ratio of 1:4). Susceptibility to cefuroxime was relatively independent of resistance to cephalothin. This was somewhat more apparent among the species of group 2 (ratio of 1:5) than among those of group 1 (ratio of 1:11).
DISCUSSION
The comparative value of the nine cephalosporins simultaneously tested in vitro against the same clinical isolates of gram-negative bacilli may be evaluated according to two different criteria. A first criterion is based on the percentage of strains that have MIC values above a critical level that is achievable in vivo after the administration of the usual dose by the usual route of administration and above which the possibility of a therapeutic success becomes highly improbable. A second criterion is based on the geometric mean MIC of the different cephalosporins for a species or a group ofspecies. It takes into account the entire range of individual MIC values from the very susceptible to the very resistant isolate within a species, and it accentuates more the therapeutic margin between the critical inhibition concentration and the mean MIC of the species or group of species.
With regard to the first criterion, the differences between the cephalosporins in the percentage of resistant isolates were rather small in the species of group 1, except for cephaloridine and cephalothin, but they were more pronounced in the species of group 2. As a whole cefamandole inhibited the highest number of isolates at the critical level, followed in decreasing order by cefazaflur < cefuroxime < cefoxitin < cefatrizine < cefazolin < cephalexin < cephaloridine < cephalothin. With regard to the second criterion and ranged in the order of increasing geometric mean MICs, the classification was: cefamandole < cefazaflur and cefuroxime < cefatrizine and cefoxitin < cefazolin < cephalexin, cephalothin, and cephaloridine.
Cefoxitin is known to be less active against Enterobacter spp. than against the other Enterobacteriaceae, but one of the most active cephalosporins against S. marcescens (3, 7, 8, 14) . In the present study an even 100% of the 30 isolates ofS. marcescens were found susceptible to 16 ,tg of cefoxitin per ml. Furthermore, cefoxitin is a cephamycin structurally different from the other cephalosporins.
This chemical difference seems to be very important, as reflected by its lack of correlation with cephalothin susceptibility (cf. Table 5 ) and its high activity against cephalothin-resistant isolates in the species of group 1 that are as a group susceptible to the older cephalosporins. From the in vitro results of this study it may be concluded that the newer generation ofcephalosporins has several advantages over the older ones.
First, they present a broader spectrum against gram-negative bacilli, extending the activity to indole-positive Proteus spp., Providencia spp., Enterobacter spp., and C. freundii. This is true especially for cefamandole, cefazaflur, cefuroxime, and cefoxitin (with the exception of Enterobacter spp. and C. freundii) but less for cefatrizine. Furthermore they inhibit gram-negative bacilli at appreciable lower MIC values, preserving activity against strains that have a low degree of resistance to the older cephalosporins. Finally, cefoxitin seems to open a new and independent class of cephalosporins that preserves largely its activity against isolates highly resistant to the other cephalosporins and that will be appreciated as a safe treatment for infection with S. marcescens.
